Discover how brain tumors evolve and develop resistance to treatments. Washington University researchers reveal insights into these deadly cancers and potential new targets for therapy. Read more: https://bit.ly/3Ah5tgG
Siteman Cancer Center’s Post
More Relevant Posts
-
Phase 1 study of this novel dual-targeting CAR T-cell therapy (named CARv3-TEAM-E) in three patients with EGFR-expressing glioblastoma has demonstrated the potential of CAR T-cell therapy to shrink aggressive brain tumors. https://lnkd.in/g62aWcxK
Brain cancer breakthrough: Tumor shrinks dramatically - Interesting Engineering
interestingengineering.com
-
🔍 Exploring the intricate landscape of brain cancer with biomarkers! 🧠 🔬 Discover how these molecular signposts are paving the way for personalized treatments in our latest article. Read more: https://lnkd.in/d4p8-SA8 #BrainCancer #Biomarkers #PrecisionMedicine
The Science Behind MyHealthVerse — Biomarkers and Brain Cancer: Tracing Paths to Targeted Treatment
medium.com
-
Are recommended cancer screening tests becoming outdated? Read more about recommended screening tests and how Synergy fills in the gap of cancer screening and early cancer detection on this week’s blog.
1 in 7 cancers are detected by a recommended screening test. Synergy's proprietary whole-body MRI, Synergy DeepScan, in combination with a multi-cancer detection blood test helps find cancers before symptoms develop. Read more on this topic below: https://lnkd.in/eXAvaUWR
Are Recommended Screening Exams Useful in Detecting Cancer? | Synergy Longevity Centers
https://www.synergylc.com
-
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development https://lnkd.in/dQVJXYq9
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development
frontiersin.org
-
📱 Your Phone Isn’t Putting You at Risk for Brain Cancer Concerned about the link between cell phone use and brain cancer? A recent study provides reassuring news about the safety of your device. Learn more about the findings and what experts say about this ongoing debate. What other health myths have you come across? Let’s discuss this in the comments! #HealthMyths #CancerAwareness #StayInformed #PublicHealth
Your Phone Isn’t Putting You at Risk of Brain Cancer
webmd.com
-
Cancer grade probing system method evaluates model tumor malignancy https://lnkd.in/gsJz2sqh
Cancer grade probing system method evaluates model tumor malignancy
medicalxpress.com
-
Cancer grade probing system method evaluates model tumor malignancy https://lnkd.in/gsJz2sqh
Cancer grade probing system method evaluates model tumor malignancy
medicalxpress.com
-
Cancer grade probing system method evaluates model tumor malignancy https://lnkd.in/gWgP7C_g
Cancer grade probing system method evaluates model tumor malignancy
medicalxpress.com
-
Will #CAR-T work in a complex solid tumor like #GBM? An initial hope comes from a FIH, investigator-initiated, open-label study on 3 patients with recurrent glioblastoma, where a single intraventricular infusion of CARv3-TEAM-E T cells, engineered to target tumoral EGFR variant III and secrete a T-cell–engagers, resulted in rapid and robust radiographic tumor regression. https://lnkd.in/eNGxD-J6
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma | NEJM
nejm.org
-
🔬 BioGenex Presents Anti-PARP-1 Antibody for Accurate Tumor Diagnosis 🔬 BioGenex introduces the Anti-PARP-1 antibody, crucial for diagnosing various tumors. PARP-1, a DNA-binding enzyme, plays a vital role in DNA repair and acts as an early marker of apoptosis. It's overexpressed in tumors like malignant melanomas, colorectal, breast, and testicular cancers, contributing to their progression. Our ready-to-use (RTU) and concentrated B&T Cell Associated Lymphoma Panel, compatible with manual and automated systems, supports precise clinicopathological diagnosis and drug discovery, helping clinicians improve patient outcomes. Learn More: https://hubs.la/Q02Mcchy0 #TumorDiagnosis #PARP1 #CancerResearch #Pathology #BioGenex #ClinicalDiagnostics
-
